Editorial
Voluntary blood donation: challenges in COVID-19 pandemic—Indian scenario
Annals of Blood
2020;
5:
21
(30 September 2020)
Editorial Commentary
Platelet transfusion in the real life
Annals of Blood
2020;
5:
20
(30 June 2020)
Editorial Commentary
Iatrogenic anemia: an underestimated and solvable problem in the intensive care unit
Annals of Blood
2020;
5:
19
(30 June 2020)
Editorial Commentary
Aging, chronic inflammation, and platelet hyperactivity
Annals of Blood
2020;
5:
18
(30 June 2020)
Editorial Commentary
Antigen glycosylation broadens the immunogenicity of E2 subunit HCV vaccines
Annals of Blood
2020;
5:
17
(30 June 2020)
Editorial Commentary
Changing donor policy for men who have sex with men: it’s all about the data
Annals of Blood
2020;
5:
16
(30 June 2020)
Review Article
Human leukocyte antigen (HLA) and cancer immunotherapy: HLA-dependent and -independent adoptive immunotherapies
Annals of Blood
2020;
5:
14
(30 June 2020)
Review Article
Immunotherapy for acute myeloid leukemia: the dawn of a new era?
Annals of Blood
2020;
5:
13
(30 June 2020)
Original Article
Tim-3 expression on t cells is correlated with liver inflammation, fibrosis and virological characteristics in treatment-naïve chronic hepatitis B patients: a cross-sectional study
Annals of Blood
2020;
5:
12
(30 June 2020)
Editorial
Consistent accuracy: a goal for thrombosis and hemostasis testing is accomplished using an external quality assurance program
Annals of Blood
2020;
5:
11
(30 June 2020)
Editorial Commentary
Inflammation mediated platelet hyperactivity in aging
Annals of Blood
2020;
5:
10
(25 March 2020)
Guideline
Guidance on the establishment, implementation and performance for proficiency testing programs for thrombosis and hemostasis
Annals of Blood
2020;
5:
9
(25 March 2020)
Review Article
Exploring the tumor promoting role of anti-tumor macrophage: a developmental perspective
Annals of Blood
2020;
5:
8
(25 March 2020)
Brief Report
Ongoing improvements in laboratory performance of coagulation factors VIII and IX: recent experience from the RCPAQAP
Annals of Blood
2020;
5:
7
(25 March 2020)
Brief Report
The changing face of activated protein C resistance testing—a 10-year retrospective
Annals of Blood
2020;
5:
6
(25 March 2020)
Review Article
Cancer immunotherapy using T-cell receptor engineered T cell
Annals of Blood
2020;
5:
5
(25 March 2020)
Review Article
The multifactorial roles of IL-34 in immune responses
Annals of Blood
2020;
5:
4
(25 March 2020)
Review Article
Anticoagulation therapy in France: state-of-the-art in 2020
Annals of Blood
2020;
5:
3
(25 March 2020)
Review Article
The role of bone marrow stromal cells in blood diseases and clinical significance as a crucial part of the hematopoietic microenvironment
Annals of Blood
2020;
5:
2
(25 March 2020)
Original Article
Comparison of erythrocyte indices and haematological indices as markers of iron status of lagos children with cyanotic congenital heart disease
Annals of Blood
2020;
5:
1
(25 March 2020)
Original Article
Characterization of high-purity, double virus inactivated and stable plasma-derived anti-haemophilic clotting factor-VIII/vWF complex
Annals of Blood
2019;
4:
31
(31 December 2019)
Original Article
The efficacy of HBsAg detection using electro-chemiluminescence immunoassay for blood donor screening in China
Annals of Blood
2019;
4:
30
(31 December 2019)
Review Article
Platelet physiology and immunology: pathogenesis and treatment of classical and non-classical fetal and neonatal alloimmune thrombocytopenia
Annals of Blood
2019;
4:
29
(26 December 2019)
Editorial Commentary
Towards a cure: using edited hematopoietic stem cells
Annals of Blood
2019;
4:
28
(17 December 2019)